BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 17470642)

  • 1. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity.
    Kim TW; Staschke K; Bulek K; Yao J; Peters K; Oh KH; Vandenburg Y; Xiao H; Qian W; Hamilton T; Min B; Sen G; Gilmour R; Li X
    J Exp Med; 2007 May; 204(5):1025-36. PubMed ID: 17470642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRAK4 in TLR/IL-1R signaling: possible clinical applications.
    Li X
    Eur J Immunol; 2008 Mar; 38(3):614-8. PubMed ID: 18286571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling.
    Kawagoe T; Sato S; Jung A; Yamamoto M; Matsui K; Kato H; Uematsu S; Takeuchi O; Akira S
    J Exp Med; 2007 May; 204(5):1013-24. PubMed ID: 17485511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the interleukin 1 receptor-associated kinase 4 (IRAK4)-encoding gene in salmonid fish: the functional copy is rearranged in Oncorhynchus mykiss and that factor can impair TLR signaling in mammalian cells.
    Brietzke A; Goldammer T; Rebl H; Korytář T; Köllner B; Yang W; Rebl A; Seyfert HM
    Fish Shellfish Immunol; 2014 Jan; 36(1):206-14. PubMed ID: 24239597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency in IRAK4 activity attenuates manifestations of murine Lupus.
    Murphy M; Pattabiraman G; Manavalan TT; Medvedev AE
    Eur J Immunol; 2017 May; 47(5):880-891. PubMed ID: 28295231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific manner.
    Cushing L; Stochaj W; Siegel M; Czerwinski R; Dower K; Wright Q; Hirschfield M; Casanova JL; Picard C; Puel A; Lin LL; Rao VR
    J Biol Chem; 2014 Apr; 289(15):10865-10875. PubMed ID: 24567333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling.
    De Nardo D; Balka KR; Cardona Gloria Y; Rao VR; Latz E; Masters SL
    J Biol Chem; 2018 Sep; 293(39):15195-15207. PubMed ID: 30076215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRAK4 activity controls immune responses to intracellular bacteria Listeria monocytogenes and Mycobacterium smegmatis.
    Pattabiraman G; Murphy M; Agliano F; Karlinsey K; Medvedev AE
    J Leukoc Biol; 2018 Oct; 104(4):811-820. PubMed ID: 29749650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein tyrosine phosphatase SHP-1 positively regulates TLR-induced IL-12p40 production in macrophages through inhibition of phosphatidylinositol 3-kinase.
    Zhou D; Collins CA; Wu P; Brown EJ
    J Leukoc Biol; 2010 May; 87(5):845-55. PubMed ID: 20145200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solving the IRAK-4 enigma: application of kinase-dead knock-in mice.
    Koziczak-Holbro M; Joyce C; Glück A; Kinzel B; Müller M; Gram H
    Ernst Schering Found Symp Proc; 2007; (3):63-82. PubMed ID: 18510099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses.
    Lye E; Dhanji S; Calzascia T; Elford AR; Ohashi PS
    Eur J Immunol; 2008 Mar; 38(3):870-6. PubMed ID: 18286567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
    Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
    J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRAK-M regulates the inhibition of TLR-mediated macrophage immune response during late in vitro Leishmania donovani infection.
    Srivastav S; Saha A; Barua J; Ukil A; Das PK
    Eur J Immunol; 2015 Oct; 45(10):2787-97. PubMed ID: 26140693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages.
    Rowlett RM; Chrestensen CA; Nyce M; Harp MG; Pelo JW; Cominelli F; Ernst PB; Pizarro TT; Sturgill TW; Worthington MT
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G452-9. PubMed ID: 18032482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two phases of inflammatory mediator production defined by the study of IRAK2 and IRAK1 knock-in mice.
    Pauls E; Nanda SK; Smith H; Toth R; Arthur JSC; Cohen P
    J Immunol; 2013 Sep; 191(5):2717-30. PubMed ID: 23918981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone lysine methyltransferase Ezh1 promotes TLR-triggered inflammatory cytokine production by suppressing Tollip.
    Liu Y; Zhang Q; Ding Y; Li X; Zhao D; Zhao K; Guo Z; Cao X
    J Immunol; 2015 Mar; 194(6):2838-46. PubMed ID: 25687760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRAK4 as a molecular target in the amelioration of innate immunity-related endotoxic shock and acute liver injury by chlorogenic acid.
    Park SH; Baek SI; Yun J; Lee S; Yoon DY; Jung JK; Jung SH; Hwang BY; Hong JT; Han SB; Kim Y
    J Immunol; 2015 Feb; 194(3):1122-30. PubMed ID: 25548221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of IRAK4 and IRF3 in the control of intracellular infection with Chlamydia pneumoniae.
    Trumstedt C; Eriksson E; Lundberg AM; Yang TB; Yan ZQ; Wigzell H; Rottenberg ME
    J Leukoc Biol; 2007 Jun; 81(6):1591-8. PubMed ID: 17360955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.
    Baird AC; Mallon D; Radford-Smith G; Boyer J; Piche T; Prescott SL; Lawrance IC; Tulic MK
    World J Gastroenterol; 2016 Nov; 22(41):9104-9116. PubMed ID: 27895398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.